Intrommune is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy.
Intrommune’s core technology enables immunotherapeutic agents to be delivered in a specially formulated toothpaste designed to incorporate and stabilize allergenic proteins, representing a new therapeutic approach for the treatment of peanut and other food allergies.
Intrommune is developing the oral mucosal immunothe...
Intrommune is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy.
Intrommune’s core technology enables immunotherapeutic agents to be delivered in a specially formulated toothpaste designed to incorporate and stabilize allergenic proteins, representing a new therapeutic approach for the treatment of peanut and other food allergies.
Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 9 million U.S. adults and 6 million U.S. children, who suffer from this life-altering condition.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.